These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 6340530)

  • 1. Regulation of angiotensinogen in cerebrospinal fluid and plasma of rats.
    Schelling P; Müller S; Clauser E
    Am J Physiol; 1983 Apr; 244(4):R466-71. PubMed ID: 6340530
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Angiotensinogen concentration in the cerebrospinal fluid in different experimental conditions in the rat.
    Ruiz P; Basso N; Grinspon D; Mangiarua E; Cannata MA
    Hypertension; 1983; 5(6 Pt 3):V29-33. PubMed ID: 6360880
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation of angiotensinogen in the central nervous system.
    Schelling P; Clauser E; Felix D
    Clin Exp Hypertens A; 1983; 5(7-8):1047-61. PubMed ID: 6357557
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of converting-enzyme inhibition on rat des-angiotensin I-angiotensinogen.
    Clauser E; Bouhnik J; Gonzalez MF; Corvol P; Menard J
    Am J Physiol; 1984 Feb; 246(2 Pt 1):E129-33. PubMed ID: 6320670
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effects of converting enzyme inhibitors on plasma angiotensinogen and plasma aldosterone in sodium-depleted rats.
    Clauser E; Gonzalez MF; Bouhnik J; Corvol P; Ménard J
    J Hypertens Suppl; 1983 Oct; 1(1):37-40. PubMed ID: 6100608
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Changes in angiotensinogen and des-angiotensin I-angiotensinogen in man and rat upon inhibition of converting enzyme].
    Clauser E; Genain C; Bouhnik J; Corvol P; Ménard J
    Arch Mal Coeur Vaiss; 1982 Jun; 75 Spec No():157-61. PubMed ID: 6287956
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Angiotensinogen production and consumption in the adrenalectomized rat.
    Clauser E; Bouhnik J; Jaramillo HN; Auzan C; Corvol P; Menard J
    Endocrinology; 1985 Jan; 116(1):274-80. PubMed ID: 3880542
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The brain renin-angiotensin system and the development of DOC-salt hypertension.
    Basso N; Ruiz P; Kurnjek ML; Cannata MA; Taquini AC
    Clin Exp Hypertens A; 1985; 7(9):1259-68. PubMed ID: 3907896
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Angiotensinogen in rat cerebrospinal fluid.
    Hilgenfeldt U
    Clin Exp Hypertens A; 1984; 6(10-11):1815-24. PubMed ID: 6532575
    [No Abstract]   [Full Text] [Related]  

  • 10. Characterization of plasma and cerebrospinal fluid human angiotensinogen and des-angiotensin I-angiotensinogen by direct radioimmunoassay.
    Genain C; Bouhnik J; Tewksbury D; Corvol P; Menard J
    J Clin Endocrinol Metab; 1984 Sep; 59(3):478-84. PubMed ID: 6746861
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of angiotensinogen concentration on renin activity following nephrectomy and adrenalectomy: implications in the activation of plasma prorenin.
    Evans DB; Cornette JC; Sharma SK
    Clin Exp Hypertens A; 1990; 12(8):1473-87. PubMed ID: 2081376
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clearance of rabbit plasma angiotensinogen and relationship to CSF angiotensinogen.
    Lewicki JA; Printz JM; Printz MP
    Am J Physiol; 1983 Apr; 244(4):H577-85. PubMed ID: 6837758
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of hepatic angiotensinogen gene expression in nephrotic rats.
    Medina-Campos ON; Pedraza-Chaverrí J; Correa-Rotter R; Ibarra-Rubio ME
    Clin Exp Hypertens; 1997 Apr; 19(3):343-62. PubMed ID: 9107441
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Liver angiotensinogen synthesis and release during captopril treatment in sodium-depleted rats.
    Jaramillo HN; Sambhi MP; Bouhnik J; Corvol P; Menard J
    Endocrinology; 1987 Apr; 120(4):1384-90. PubMed ID: 3030698
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Converting enzyme inhibitor-induced changes of plasma angiotensinogen concentration in the rat.
    Radziwill R; Stuzmann M; Hilgenfeldt U; Hackenthal E
    Eur J Pharmacol; 1986 Mar; 122(1):59-64. PubMed ID: 3007179
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Angiotensinogen levels in the brain and cerebrospinal fluid of the genetically hypertensive rat.
    Healy DP; Printz MP
    Hypertension; 1985; 7(5):752-9. PubMed ID: 4030046
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vivo enzyme activity of purified human brain renin.
    Rettig R; Speck G; Simon W; Schelling P; Fahrer A; Ganten D
    Klin Wochenschr; 1978; 56 Suppl 1():43-5. PubMed ID: 732251
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential effects of nephrectomy and surgery on plasma kininogens and angiotensinogen in the rat.
    Suzuki H; Alhenc-Gelas F; Bouhnik J; Corvol P; Ménard J
    Endocrinology; 1988 Jun; 122(6):2809-15. PubMed ID: 3371263
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Studies on angiotensinogen of plasma and cerebrospinal fluid in normal and hypertensive human subjects.
    Ito T; Eggena P; Barrett JD; Katz D; Metter J; Sambhi MP
    Hypertension; 1980; 2(4):432-6. PubMed ID: 7399627
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Elevated angiotensinogen mRNA levels in rat liver by nephrectomy.
    Iwao H; Kimura S; Fukui K; Nakamura A; Tamaki T; Ohkubo H; Nakanishi S; Abe Y
    Am J Physiol; 1990 Mar; 258(3 Pt 1):E413-7. PubMed ID: 2180313
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.